title: Fine-tuning risk assessment with antiepileptic drug use in pregnancy.
authors.affiliation: From the Department of Clinical Neuroscience (T.T.), Karolinska Institutet, Stockholm, Sweden; and Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD. torbjorn.tomson@karolinska.se.
authors.forename: Torbjörn
authors.initials: T
authors.lastname: Tomson
authors.affiliation: From the Department of Clinical Neuroscience (T.T.), Karolinska Institutet, Stockholm, Sweden; and Mid-Atlantic Epilepsy and Sleep Center (P.K.), Bethesda, MD.
authors.forename: Pavel
authors.initials: P
authors.lastname: Klein
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects*; D002220:Carbamazepine / Q000009:adverse effects*; D002657:Child Development / Q000187:drug effects*; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007360:Intelligence / Q000187:drug effects*; D000077213:Lamotrigine; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced*; D014227:Triazines / Q000009:adverse effects*; D014635:Valproic Acid / Q000009:adverse effects*
chemical_list: D000927:Anticonvulsants; D014227:Triazines; D002220:Carbamazepine; D014635:Valproic Acid; D000077213:Lamotrigine